HENNER DENNIS

CIK 000124915327 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001249153

Recent Transactions

50 trades

Disposition to Issuer
Imago BioSciences, Inc.
Stock Option (Right to Buy)
2023-01-11−11,904→ 0 total
Disposition from Tender
Imago BioSciences, Inc.
Common Stock
2023-01-11$36.00/sh−26,095→ 0 total
Award
Imago BioSciences, Inc.
Stock Option (Right to Buy)
2022-06-01+11,904→ 0 total
Disposition to Issuer
Forty Seven, Inc.
Stock Option (right to buy)
2020-04-07−20,645→ 0 total
Disposition to Issuer
Forty Seven, Inc.
Stock Option (right to buy)
2020-04-07−10,322→ 0 total
Award
Forty Seven, Inc.
Stock Option (right to buy)
2019-06-12+10,322→ 10,322 total
Conversion
Entasis Therapeutics Holdings Inc.
Series B-1 Tranche B Convertible Preferred Stock
2018-09-28−8,552,024→ 0 total
Conversion
Entasis Therapeutics Holdings Inc.
Common Stock
2018-09-28+412,583→ 1,170,010 total
Conversion
Entasis Therapeutics Holdings Inc.
Common Stock
2018-09-28+323,341→ 685,170 total
Conversion
Entasis Therapeutics Holdings Inc.
Series B-1 Tranche A Convertible Preferred Stock
2018-09-28−6,702,213→ 0 total
Conversion
Entasis Therapeutics Holdings Inc.
Common Stock
2018-09-28+361,829→ 361,829 total
Purchase
Entasis Therapeutics Holdings Inc.
Common Stock
2018-09-28$15.00/sh+453,395→ 1,623,405 total
Conversion
Entasis Therapeutics Holdings Inc.
Series B Convertible Preferred Stock
2018-09-28−7,500,000→ 0 total
Conversion
Forty Seven, Inc.
Common Stock
2018-07-02+755,780→ 1,694,269 total
Conversion
Forty Seven, Inc.
Common Stock
2018-07-02+755,780→ 1,694,269 total
Conversion
Forty Seven, Inc.
Series A-2 Preferred Stock
2018-07-02−755,780→ 0 total
Conversion
Forty Seven, Inc.
Series B Preferred Stock
2018-07-02−1,922,682→ 0 total
Purchase
Forty Seven, Inc.
Common Stock
2018-07-02$16.00/sh+200,000→ 3,816,951 total
Conversion
Forty Seven, Inc.
Common Stock
2018-07-02+938,489→ 938,489 total
Purchase
Forty Seven, Inc.
Common Stock
2018-07-02$16.00/sh+200,000→ 3,816,951 total
Conversion
Forty Seven, Inc.
Series A-1 Preferred Stock
2018-07-02−938,489→ 0 total
Conversion
Forty Seven, Inc.
Common Stock
2018-07-02+1,922,682→ 3,616,951 total
Conversion
Forty Seven, Inc.
Common Stock
2018-07-02+1,922,682→ 3,616,951 total
Conversion
Forty Seven, Inc.
Common Stock
2018-07-02+938,489→ 938,489 total
Conversion
Forty Seven, Inc.
Series B Preferred Stock
2018-07-02−1,922,682→ 0 total
Conversion
Forty Seven, Inc.
Series A-2 Preferred Stock
2018-07-02−755,780→ 0 total
Conversion
Forty Seven, Inc.
Series A-1 Preferred Stock
2018-07-02−938,489→ 0 total
Conversion
Venus Concept Inc.$VERO
Common Stock
2017-10-16$7.00/sh+180,881→ 3,569,986 total
Conversion
Venus Concept Inc.$VERO
Series C Preferred Stock
2017-10-16−3,389,105→ 0 total
Conversion
Venus Concept Inc.$VERO
Convertible Promissory Note
2017-10-16→ 0 total
Conversion
Venus Concept Inc.$VERO
Common Stock
2017-10-16+3,389,105→ 3,389,105 total
Other
Venus Concept Inc.$VERO
Convertible Promissory Note
2017-10-11$1259269.79/sh
Other
Radius Health, Inc.
Common Stock
2016-09-27−1,229,902→ 2,459,804 total
Sale
TETRALOGIC PHARMACEUTICALS Corp
Common Stock
2016-02-09$0.16/sh−230,507→ 2,214,523 total
Sale
TETRALOGIC PHARMACEUTICALS Corp
Common Stock
2016-02-08$0.19/sh−103,123→ 2,445,030 total
Sale
TETRALOGIC PHARMACEUTICALS Corp
Common Stock
2016-02-05$0.20/sh−832,881→ 2,548,153 total
Sale
TETRALOGIC PHARMACEUTICALS Corp
Common Stock
2016-02-04$0.14/sh−500,026→ 3,381,034 total
Sale
TETRALOGIC PHARMACEUTICALS Corp
Common Stock
2016-02-03$0.15/sh−82,583→ 3,881,060 total
Sale
TETRALOGIC PHARMACEUTICALS Corp
Common Stock
2016-02-02$0.17/sh−176,306→ 3,963,643 total
Sale
TETRALOGIC PHARMACEUTICALS Corp
Common Stock
2016-02-01$0.20/sh−140,000→ 4,139,949 total
Sale
TETRALOGIC PHARMACEUTICALS Corp
Common Stock
2016-01-29$0.26/sh−52,826→ 4,279,949 total
Sale
TETRALOGIC PHARMACEUTICALS Corp
Common Stock
2016-01-28$0.26/sh−32,521→ 4,332,775 total
Sale
TETRALOGIC PHARMACEUTICALS Corp
Common Stock
2016-01-27$0.27/sh−209,984→ 4,365,296 total
Sale
TETRALOGIC PHARMACEUTICALS Corp
Common Stock
2016-01-26$0.30/sh−69,425→ 4,575,280 total
Sale
Oxford Immunotec Global PLC
Ordinary Shares
2015-06-16$14.30/sh−39,701→ 2,237,377 total
Sale
Oxford Immunotec Global PLC
Ordinary Shares
2015-06-15$14.27/sh−1,529→ 2,277,078 total
Sale
Oxford Immunotec Global PLC
Ordinary Shares
2015-06-12$14.25/sh−6,430→ 2,278,607 total
Sale
Oxford Immunotec Global PLC
Ordinary Shares
2015-06-11$14.27/sh−25,168→ 2,285,037 total
Sale
Oxford Immunotec Global PLC
Ordinary Shares
2015-06-10$14.32/sh−8,987→ 2,310,205 total
Sale
Oxford Immunotec Global PLC
Ordinary Shares
2015-06-09$14.26/sh−13,000→ 2,319,192 total

Companies

Recent Filings

Address

C/O CLARUS VENTURES, LLC 101 MAIN STREET, SUITE 1210

CAMBRIDGE, MA, 02142

View on SEC.gov